[Federal Register Volume 66, Number 128 (Tuesday, July 3, 2001)]
[Notices]
[Page 35268]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-16679]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated September 8, 2000, and published in the Federal 
Register on September 25, 2000 (65 FR 57621), Abbott Laboratories, 1776 
North Centennial Drive, McPherson, Kansas 67460-1247, made application 
to the Drug Enforcement Administration (DEA) to be registered as an 
importer of remifentanil (9739), a basic class of controlled substance 
listed in Schedule II.
    The firm plans to import the remifentanil to manufacture Ultiva for 
the U.S. market.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Abbott Laboratories to import 
remifentanil is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Abbott Laboratories on a regular basis to ensure that the company's 
continued registration is consistent with the public interest. This 
investigation included inspection and testing of the company's physical 
security systems, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to section 1008(a) of the Controlled Substances 
Import and Export Act and in accordance with Title 21, Code of Federal 
Regulations, Sec. 1301.34, the above firm is granted registration as an 
importer of the basic class of controlled substance listed above.

    Dated: June 22, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-16679 Filed 7-2-01; 8:45 am]
BILLING CODE 4410-09-M